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Abstract
In oxidosqualene cyclases (OSCs), an enzyme which has been extensively studied as a target for hypocholesterolemic or
antifungal drugs, a lipophilic channel connects the surface of the protein with the active site cavity. Active site and channel
are separated by a narrow constriction operating as a mobile gate for the substrate passage. In Saccharomyces cerevisiae
OSC, two aminoacidic residues of the channel/constriction apparatus, Ala525 and Glu526, were previously showed as critical
for maintaining the enzyme functionality. In this work sixteen novel mutants, each bearing a substitution at or around the
channel constrictions, were tested for their enzymatic activity. Modelling studies showed that the most functionality-
lowering substitutions deeply alter the H-bond network involving the channel/constriction apparatus. A rotation of Tyr239
is proposed as part of the mechanism permitting the access of the substrate to the active site. The inhibition of OSC by
squalene was used as a tool for understanding whether the residues under study are involved in a pre-catalytic selection
and docking of the substrate oxidosqualene.
Citation: Oliaro-Bosso S, Caron G, Taramino S, Ermondi G, Viola F, et al. (2011) Characterization of the Channel Constriction Allowing the Access of the Substrate
to the Active Site of Yeast Oxidosqualene Cyclase. PLoS ONE 6(7): e22134. doi:10.1371/journal.pone.0022134
Editor: Annalisa Pastore, National Institute for Medical Research, Medical Research Council, United Kingdom
Received November 29, 2010; Accepted June 16, 2011; Published July 21, 2011
Copyright:  2011 Oliaro-Bosso et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the University of Turin (MIUR ex 60%) and the regional government (Regione Piemonte). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gianni.balliano@unito.it
Introduction
In sterol biosynthesis, oxidosqualene cyclases (OSCs) catalyze the
most outstanding structural alteration step of the pathway: the
shaping of the totally open triterpene intermediate 2,3-oxidosqua-
lene, generated by the mevalonate pathway, into a polycyclic
steroid, namely lanosterol in non-photosynthetic eukaryotes or
cycloartenol in photosynthetic eukaryotes. In prokaryotes, an
enzyme similar to oxidosqualene cyclases, squalene-hopene cyclase
(SHC), catalyzes the cyclization of the triterpene squalene. For more
than fifty years, a large number of studies has been addressed to the
understanding of the complex catalytic mechanism of squalene- and
oxidosqualene cyclizing enzymes [1,2]. Milestones of this long
scientific pathway are the solution of the crystal structure of SHC
from Alicyclobacillus acidocaldarius in 1997 [3] and human OSC
(HsaOSC) in 2004 [4]. The structural analyses of both SHC and
HsaOSC revealed the essential features of the active sites, and
evidenced also the presence of a lipophilic channel connecting the
surface of the protein with the active site cavity. Active site and
channel are separated by a narrow constriction formed by few
aminoacid residues operating as a mobile gate for the substrate
passage [5,6]. The structural analysis of both the channel and the
channel constriction of SHC and OSCs suggests that they play a
role in capturing the substrate and docking it to the active site cavity.
In eukaryotes, the channel might even play a more important role as
it could guide the asymmetric substrate squalene epoxide to the
active site with the correct orientation, so that the epoxide group
interacts with the catalytic residues to trigger the cyclization process
[7]. We have previously pointed out the critical role of the channel
and the constriction of yeast OSC through an inhibition and site-
directed mutagenesis approach [6]. Our results show that two
residues, Ala525 and Glu526, close to the channel constriction, are
critical for both the protein conformational stability and the
susceptibility to irreversible inhibition. In the present study, 16 novel
mutants of S. cerevisiae (SceOSC) have been prepared and tested for
their catalytic activity. Some of them were designed to extend the
study of the previously selected position Ala525, others were
suggested by the interactions shown in the modelling study by the
residues His193, Asn211, His291 [6], others, finally, were designed
on the basis of the structural role assigned to the corresponding
residues Tyr237 and Cys233 inHsaOSC [4]. To make it possible to
compare results of the present and previous study, all the novel
mutants have been built starting from the mutant C457D, housing a
CRD mutation in the active site cavity, used in our first site-
directed mutagenesis study [6].
Several of the novel mutants of this study were less active than
the control, pointing out the critical pre-catalytic role of the
channel and channel constriction in SceOSC. One of the new
mutants studied, C457D/N211K, revealed a high thermal
instability, confirming that the alteration of the complex H-
bonding network around the Glu526 residue, as previously shown
[6], is critical for the enzyme functionality.
Results of the enzymatic assays are discussed with the help of
models of the 3D structures of mutant proteins.
We have also checked the ability of the channel and constriction
of OSC to properly dock the substrate, and studied the putative
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different ability of mutants to distinguish epoxide- from non-
epoxide end of the substrate by testing their sensitivity to squalene
as a possible competitive inhibitor.
The study will contribute to depict structural features that made
OSCs capable of a pre-catalitically recognition of the substrate
oxidosqualene, a supposed critical step to boost the catalytic
reaction. Moreover, the design of new OSC inhibitors, as potential
tools for cholesterol-lowering or antifungal/antiparasitic therapy
[8,9], could take advantage from the identification of structurally
crucial aminoacid residues.
Results and Discussion
SceOSC and mutant models
Firstly, by using the X-Ray structure of the HsaOSC (pdb code:
1W6K), a homology model of SceOSC was built (see Materials and
Methods and Table S1 in supporting informations for details).
Once obtained the SceOSC model, its active site (in green in
Figure 1A) was recognized by comparison with the HsaOSC
structure 1W6K to facilitate the visual detection of the
information, to date available, about the channel and its
constriction. In particular, Figure 1B shows the four aminoacids
(Trp231, Tyr239, Ala525, Glu526) hypothesized to form the
channel constriction on the basis of SHC-based considerations,
whereas Figure 1C shows the three aminoacids (Tyr239, Thr235
and Ile531) suggested by the literature as responsible for the
substrate passage in the HsaOSC structure [4].
The six aminoacid residues (His193, Asn211, His291, Tyr239,
Thr235 and Ala525) object of this study, together with Glu526
investigated in a previous report [6], are in Figure 1D which also
outlines their relevance to the active site.
Finally, the 3D structures of the 16 novel mutants were obtained
by MOE Rotamer Explorer tool as described in Materials and
Methods (data not shown).
Characterization of SceOSC mutants
All the novel mutants are double mutants constructed from the
C457D mutant used in our first site-directed mutagenesis study
[6]. This mutant, which possesses a CRD mutation in the active
site cavity, had initially been constructed as a control to test the
sensitivity to thiol reagents of mutants bearing an XRC
substitution around the channel constriction [6].
In the present study, the C457D mutant was maintained as a
control to make it possible both to compare results of the present
and previous study and to compare the sensitivity to thiol reagents
of Cys-bearing and non bearing mutants included in the present
study.
All the mutated genes were integrated in a SMY8 strain and
were able to abolish the auxotrophy for ergosterol of this strain.
Sequence analysis of the 16 mutated erg7 genes introduced in
the OSC-defective SMY8 strain confirmed the presence and the
location of the mutation. The catalytic activity of the correspond-
ing proteins was studied in the cell homogenates, by determining
the specific activities (Table 1).
The specific activity of almost all the new mutants was reduced
by more than 50% with respect to the control mutant C457D,
confirming the critical role of the aminoacid residues under study.
As a further control, we prepared, using exactly the same
procedure, a C457D/C619A mutant, where the mutated residue
Cys619 is, according to the structural model, far from both the
active site and the access channel. The specific activity of this
mutant is 2.360.49, not significantly different from that of control
mutant C457D.
Four mutants, namely C457D/A525F, C457D/A525Y,
C457D/Y239F and C457D/N211K, have a very low specific
activity, ranging from 10 to 20% of the control C457D.
Nevertheless, the low OSC activity of these four mutants was
sufficient to support growth in the absence of added ergosterol, as
shown by spot plate tests (Figure 2). Under the same conditions,
the growth of the defective strain SMY8 was completely abolished.
A complex network of hydrogen bonds helps in
maintaining the conformation of the constriction loop
and the full activity of the enzyme
The aminoacid residues in positions 525, 193, 211, 291,
according to our model of SceOSC and to the crystal structure of
HsaOSC contribute to the stabilization of the channel and channel
constriction, forming a wide net of hydrogen bonds. In particular,
A525, which is located inward from the channel constriction
towards the active site, seems to stabilize the conformation of the
constriction loop through a direct interaction of its backbone NH
group with the side chain of the in-sequence-neighbouring
Asn523, while His193, Asn211, and His291 interact one another
and with Glu526, a residue identified in previous work as crucial in
keeping the functionality and stability of the yeast enzyme [6].
The results obtained with the mutants C457D/A525I,
C457D/A525L, C457D/A525F, C457D/A525Y, show a
reduction of activity following the substitution of Ala525 with
residues bearing bulky aromatic or alkyl side chains in a bulk-
dependent manner: the two mutants A525Y and A525F, bearing
aromatic residues, were both less active than the two mutants
A525I and A525L, bearing long alkyl side chains (Table 1). In
agreement with the enzymatic activity results, the modelling
studies show that the Phe or Tyr aromatic side chain fill the
channel to the active site much more than the Ile or Leu side
chains (see Figure S1 in supporting informations). In addition, we
had previously observed that the substitution of Ala525 with a
cysteine, a residue with a roughly comparable size, that does not
impair the hydrogen bond network, caused only a slight decrease
in enzymatic activity [6]. Similarly all the mutants at the position
193, 211, 291, i.e. C457D/H193A, C457D/H193N, C457D/
N211A, C457D/N211D, C457D/N211Q, C457D/N211K,
C457D/H291A, C457D/H291N, caused the lowering by at
least 50% of the enzymatic activity, the more effective one being
the C457D/N211K, which in addition proved to be extremely
unstable at 35uC, as demonstrated by results of two different
experiments of termal inactivation showed in figures 3 and 4. The
time-course experiments (Figure 3B) showed that the activity at
35uC of mutant C457D/N211K was close to zero after 20 min
and did not increase during 4 h of incubation, but it slowly
increased during 4 h of incubation at 25uC, while the activity of
control C457D and of the other mutants tested (C457D/A525F
and C457D/Y239F) increased regularly at both temperatures.
The activity of all the mutants in position 211, determined at
25uC, significantly decreased after preincubation at 35uC in the
absence of substrate. The activities of the control C457D and the
mutant C457D/A525F were not affected by the preincubation at
35uC, as shown in Figure 4, thus pointing out that mutations
different from those at position 211 did not affect the thermal
stability of the protein.
This picture is supported by the results of a normal mode
analysis (NMA) of SceOSC based on an anisotropic netwok model
(ANM) [10]. The NMA approach can be used to describe intrinsic
protein fluctuations in place of the more computational time
demanding Molecular Dynamics. In particular, NMA provided
the correlation between the residues fluctuations responsible of the
intrinsic motions of the protein around its native state conforma-
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tion. NMA showed a correlation between the motion of residues in
position 193, 211, 291, 525 and 526 (see Materials and Methods,
Supporting Text S1, Figure S2 and Table S2 in supporting
informations for details). These results reinforce the hypothesis
that a modification in the hydrogen bond pattern of any of the five
aminoacids (His193, Asn211, His291, Ala525 and Glu526) is
expected to alter the whole hydrogen bond pattern of the involved
substructure.
In summary, all the substitutions at the position 525 and at the
three positions interacting with Glu526, i.e. 193, 211, 291, caused
the lowering of the enzymatic activity, the more effective ones
being those at position 211, in particular C457D/N211K, where
the insertion of a Lys residue (in substitution of Asn) between two
His residues (193 and 291) possibly positively charged at
physiological pH, likely causes an excess of positive charges near
the constriction which could be responsible for the reduced activity
and thermal instability.
A change of conformation of a Tyr residue allows the
access to the active site through the channel
Substitutions at positions 239 (Tyr) and 235 (Thr) (mutants
C457D/Y239F, C457D/Y239A, C457D/T235A, C457D/
T235C) were designed on the basis of the structural role assigned
to the corresponding residues Tyr237 and Cys233 in HsaOSC,
that were supposed to change their side chain conformation to
allow the passage of the substrate through the channel constric-
tion. Interestingly, the simple removal of an hydroxyl group, as in
the C457D/Y239F mutant, caused the most dramatic lowering of
the enzyme activity (less than 20% of the control), while the
substitution Tyr to Ala only reduced the activity to a half (Table 1).
Molecular modelling suggests that Tyr239 fills the middle
portion of the lipophilic channel constriction with its bulky side
chain. A rotation of the side chain stabilized by a hydrogen bond
bridge with Pro228 could open the channel and enable the
substrate to enter the active site. The replacement of tyrosine with
phenylalanine in mutant Y239F keeps the channel in a closed
conformation, possibly causing the observed decrease of enzymatic
activity. By replacement of tyrosine with a smaller aminoacidic
residue, such as alanine, the channel is probably always open and
the substrate can freely access to the catalytic site (Figure 5), also
when it is in an uncorrect orientation: this could explain the 50%
loss of activity. A similar flip of a tyrosine residue was reported for
some enzymes belonging to the catechol 1,2-dioxygenase family
[11]. The alignment with Blink (http://www.ncbi.nlm.nih.gov/
sutils/blink.cgi) show that most yeast and animal OSCs have a Tyr
residue at 239 position (S. cerevisiae numbering), whereas most
bacterial squalene hopene cyclases (SHC), accepting as a substrate
the symmetric molecule of squalene, possess a Val or Ile residue at
the corresponding constriction-forming position. We speculate
that in the OSCs bearing a Tyr at the 239 position, the control
Figure 1. SceOSC and mutant models. A) SceOSC active site (in green) and lanosterol location (in yellow) as deduced from HsaOSC
crystallographic data (1W6K). B) Aas involved in the channel constriction (in pink) as suggested by SHC-based considerations. C) Aas involved in the
channel constriction (in orange) as suggested HsaOSC-based considerations. D) Mutated residues studied in this work (together with Glu526 shown
for comparison).
doi:10.1371/journal.pone.0022134.g001
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mechanism of the selective access of the substrate to the active site
could be partially ascribed to the rotation of the Tyr residue.
As a further support to this hypothesis, by submitting the
SceOSC model to CAVER, a program that identifies and visualizes
routes from the interior of the protein to the bulk solvent (see
Materials and Methods), the access to the active site was found
only if the Tyr239 residue is maintained in a rotated position by
the formation of a H-bond with Pro228, a condition that cannot
be met when the Tyr239 was substituted by a Phe residue
(Figure 6).
The mutations C457D/T235A and C457D/T235C point
out that also the loss of a hydrogen bond between Thr235 and
Ile531( (clearly visible in our model of SceOSC), could be relevant
for maintaining the conditions for the proper accessibility to the
active site. The mutant C457D/T235C did not demonstrate a
higher sensitivity to the thiol reagent dodecyl-maleimide, showing
a minor accessibility than expected.
Effect of squalene as a competitive inhibitor
The effect of squalene as a possible competitive inhibitor was
checked in order to evaluate the role of channel and channel
constriction of OSC in the pre-catalytic selection of the substrate.
Our hypothesis was that in eukaryotic oxidosqualene cyclases the
channel is endowed with an additional function compared to
prokaryotic squalene-hopene cyclase (SHC) [12]. It is known that
SHC can transform either squalene or oxidosqualene, the latter
with a higher efficiency [13], while OSC accepts only oxidosqualene
as a substrate. An efficient substrate transformation by OSC could
occur only if oxidosqualene settles into the active site with its
epoxide properly oriented toward the protonating apparatus
responsible for triggering the cyclization process, as it is hard to
envisage a flip-flop motion inside the active site [7]. According to
this hypothesis, squalene should act as a competitive inhibitor and
the channel constriction could operate as an entropic trap able to
prefer a properly oriented molecule of substrate, in order to reduce
the risk of competitive inhibition. By testing the inhibitory effect of
different concentrations of squalene on the control mutant C457D,
we observed inhibitory effect only at concentration $0.5 mM, a
very high concentration, compared with the Km of oxidosqualene
which is in the micromolar range [14]. This suggests that the
enzyme is not completely indifferent to the competitive action of
squalene, though able to overcome its competition with substrate
under physiological conditions. We repeated the inhibition test with
the homogenates from the 16 mutants, with the working hypothesis
that a mutation in a residue involved in substrate discrimination
should cause an increased inhibition by squalene. Only in the
N211A mutant the inhibitory effect of squalene was significantly
higher (approx. 30%) than in the control enzyme, pointing out that
the Asn211 residue might be one of the structural determinants of
the channel involved in the discrimination of a properly oriented
substrate. Interestingly, Asn211 is a fully conserved residue
throughout OSCs, whereas all the known SHCs possess a Pro (a
highly conformation-altering residue) in the corresponding position.
The replacement of proline with asparagine could then be an
evolution that confers to OSCs the ability of distinguishing squalene
from oxidosqualene and properly channelling oxidosqualene.
In conclusion, on the basis of a structural model developed by
fitting the sequence of SceOSC to the HsaOSC structure, we
studied a series of SceOSC mutants bearing single aminoacid
substitutions in positions belonging or neighbouring the channel
constriction, which is supposed to operate as a mobile gate for the
substrate entering. Our aim was to provide evidences in support of
the hypothesis that the channel apparatus plays an essential role in
properly docking substrate to the active site. Most substitutions
caused a decrease in enzyme activity, thus pointing out the critical
role of the channel constriction area for the functionality of the
enzyme. The less active mutants were C457D/A525F and
C457D/A525Y, confirming the hypothesis of the involment of
Ala525 residue in the channel constriction and in a critical
hydrogen network. The failure to form a critical hydrogen bond,
allowing a conformational change of Tyr239 residue, seems also to
be involved in the poor activity of mutant C457D/Y239F, in
agreement with the suggestion of Thoma et al [4], that a
Table 1. OSC specific activity of the homogenates of the
differently transformed SMY8 strains.
SceOSC mutant * Specific Activity (nmol/h/mg protein)
C457D 1.9160.095
C457D/A525F 0.1460.036
C457D/A525Y 0.2960.090
C457D/A525I 0.7360.140
C457D/A525L 0.7560.110
C457D/H193A 0.6460.058
C457D/H193N 0.4960.077
C457D/N211A 0.6560.130
C457D/N211D 0.7960.150
C457D/N211Q 1.0060.180
C457D/N211K 0.3960.073
C457D/H291A 0.6460.140
C457D/H291N 0.8060.260
C457D/T235A 0.6760.130
C457D/T235C 0.8560.130
C457D/Y239A 0.9760.130
C457D/Y239F 0.3460.044
*Values 6 SE are the means of duplicate assays of at least two different
experiments.
doi:10.1371/journal.pone.0022134.t001
Figure 2. Spot plate analysis of SceOSC mutant strains C457D,
C457D/Y239F, C457D/A525Y, C457D/N211K and C457D/
A525F. Strains were grown on SC-L media containing galactose
supplemented with hemin. Serial tenfold dilutions, giving concentration
in the range 105–102 cells, were spotted. Pictures were taken after 4 day
incubation.
doi:10.1371/journal.pone.0022134.g002
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conformational change of Tyr239 is necessary for the entering of
the substrate.
Moreover, a deep alteration of hydrogen bond network could
explain the poor activity and thermal instability of mutants at the
position 211, particularly of C457D/N211K. In addition, experiments
with squalene as inhibitor pointed out that the residue Asn211 could
be involved in the specific pre-catalytic recognition of the substrate.
Figure 7 summarizes in a schematic way all the results found in
this study. The integrity of the channel to the active site is
guaranteed by a hydrogen bond network formed by His193,
Asn211, His291 and Glu526, whereas the active site accessibility is
due to the Tyr239 flip.
These results can contribute to design novel site-directed
inhibitors of OSCs for a potential use as antifungal or
hypocholesterolemic drugs.
Materials and Methods
Chemicals
All the components of buffers and cultural media were obtained
from Sigma-Aldrich (Milan, Italy) unless otherwise specified.
Molecular biology reagents were obtained from Promega Italia
unless otherwise specified. Squalene (S) and 2,3-oxidosqualene
(OS) were prepared as previously described [15]. The labeled
[14C]-(3S)2,3-oxidosqualene was obtained through biological
synthesis by incubating R,S[2-14C]mevalonic acid (1 mCi,
55 mCi/mmol, 2.04 GBq/mmol) (Amersham Pharmacia Biotech,
U.K.) with a pig liver S10 supernatant, in the presence of the OSC
inhibitor U-14266A [16], as previously described [17].
Yeast strains and culture conditions
The strain S. cerevisiae, lanosterol synthase mutant SMY8 (MATa
erg7::HIS3 hem1::TRP1 ura3-52-trpl-D63 leu2-3.112 his3-D200 ade2
Gal+) was kindly provided by Professor S.P.T. Matsuda (Depart-
ment of Chemistry and Biochemistry and Cell Biology, Rice
University Houston, Texas-USA) [18].
SMY8 cells were grown to the early stationary phase at 30uC in
YPD medium (1% yeast extract, 2% peptone, 2% dextrose)
supplemented with hemin (0.013 mg/mL) and ergosterol
(0.02 mg/mL). Hemin is needed in the medium as the SMY8
strains contains a mutation (hem1::TRP1) affecting the heme
biosynthesis. The presence of a heme mutant background is
necessary for the viability of lanosterol synthase mutants in aerobic
conditions [18]. SMY8 transformants were selected on synthetic
complete media plates without leucine, containing yeast nitrogen
base (0.67%), dextrose (2%), aminoacids (0.2%), nitrogen base
(0.5%), agar (2%) and supplemented with hemin (0.013 mg/mL)
and ergosterol (0.02 mg/mL). SMY8 transformed with pSM61.21
plasmids derivatives were analyzed for ergosterol autotrophy by
plating on YPG plates (1% yeast extract, 2% peptone, 2%
galactose, 2% agar) supplemented with hemin (0.013 mg/mL).
For spot plate analyses, strains were grown on synthetic
complete media plates without leucine containing yeast nitrogen
base (0.67%), galactose (2%), aminoacids (0.2%), nitrogen base
(0.5%) and supplemented with hemin. Each colony was spotted
using 5 ml from a 46105 cells/ml cell suspension. Plates were
incubated at 30uC for 96 h and scored.
Figure 3. Effect of temperature on the enzymatic activity of
mutants C457D, C457D/A525F, C457D/Y239F and C457D/
N211K. A) Percentage of labeled product per mg of protein produced
by homogenates of mutant C457D (¤,e), C457D/A525F (&,%) and
C457D/Y239F (m,n) at 35uC (filled symbols) and 25uC (empty symbols),
respectively. B) Percentage of labeled product per mg of protein
produced by homogenates of mutant C457D (¤,e) and C457D/N211K
(N, #) at 35uC (filled symbols) and 25uC (empty labels). Values are the
means of at list two separate experiments, each one carried out in
duplicate.
doi:10.1371/journal.pone.0022134.g003
Figure 4. Residual activity of mutants C457D, C457D/A525F,
C457D/N211D, C457D/N211A and C457D/N211K, after prein-
cubation at 356C. Residual enzymatic activity per mg of protein of
mutants C457D (¤), C457D/A525F (&), C457D/N211D (m), C457D/
N211A (n) and C457D/N211K (N) was determined after 30, 60, 120 and
240 min of preincubation at 35uC in the absence of substrate. Dotted
lines are used for the mutants at position 211. After preincubation, the
homogenates were incubated with substrate for 4 h at 25uC. Values are
the means of at list two separate experiments, each one carried out in
duplicate.
doi:10.1371/journal.pone.0022134.g004
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Figure 5. Tyr239 flip. The hydrogen bond between the conformation of Tyr239 enabling the access to the active site and Pro228 is shown (see text
for details).
doi:10.1371/journal.pone.0022134.g005
Figure 6. The access route to the active site proposed by CAVER is shown by cyan balls.
doi:10.1371/journal.pone.0022134.g006
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Site-directed mutagenesis
The preparation of yeast OSC mutant C457D has been
previously described [6].
To prepare the 16 novel double mutants, uracil-containing
single-stranded DNAs were prepared from phagemid pSM61.21
C457D in E. coli strain RZ1032 coinfected with M13K076 helper
phage. Mutagenic oligonucleotide was used to prime the second
strand synthesis with T4 polymerase and the DNA circle was
closed with T4 ligase [19]. E. coli strain DH5a was transformed
with the putative mutant construct and clones with the desired
mutation were validated by DNA sequencing.
Lithium acetate was used to transform the S. cerevisiae lanosterol
synthase mutant SMY8 with all the constructs [19] and
transformed cells were selected on media plates as described
above. Genomic DNA was isolated from yeast using glass beads
and phenol [19], and the OSC mutant genes were amplified with
PCR and sequenced.
DNA sequence analysis was carried out at the C.R.I.B.I. - BMR
Servizio Sequenziamento DNA, Padova (Italy). Alignments were
obtained with MultiAlin programme (http://prodes.toulouse.inra.
fr/multalin/multalin.html).
Oxidosqualene cyclase activity
Cell-free homogenates were obtained as previously described
[20]. Briefly, after lysis of the cell wall with lyticase the spheroplasts
were homogenized with a Potter device. Proteins in the
homogenate were quantified with a protein assay kit (Sigma),
based on the method of Lowry modified by Peterson [21] and by
using bovine serum albumin as a standard. OSC activity was
assayed as previously described [22]. Briefly, the homogenates
were incubated with the labeled [14C]-(3S)2,3-oxidosqualene
(1000 cpm) in MES/TRIS buffer (10 mM), containing EDTA
(0.2 mM),Triton X-100 (1 mg/mL of final volume), Tween-80
(0.2 mg/mL of final volume), pH 6.9. The standard incubation
time was 30 min at 35uC, but different times and temperatures
were used for some experiments as specified in the results. The
enzymatic reaction was terminated by the addition of KOH in
methanol (10% p/v), the lipids were saponified at 80uC for
30 min, and the nonsaponifiable lipids were extracted with
petroleum ether. Extracts were spotted on TLC plates with n-
hexane/ethyl acetate (85:15) as the developing solvent. The
conversion of the labeled substrate to labeled product was
determined by using a System 200 imaging scanner ( Hewlett
Packard, Palo Alto CA, USA).
Oxidosqualene cyclase inhibition by squalene and
dodecyl-maleimide
OSC inhibition was carried out, as described above, by
incubating the homogenate with the labeled [14C]-(3S)2,3-
oxidosqualene (1000 cpm) diluted with cold (R,S)2,3-oxidosqua-
lene to a final concentration 25 mm, in the presence of dodecyl-
maleimide (1 mM, 0.2 mM, 25 mM) or squalene (500 mM),
respectively for 30 min and 1 h at 35uC. When squalene was
the inhibitor, the concentration of Tween-80 and Triton X-100
was respectively 0.1 mg/mL and 1 mg/mL of final volume.
Computational methods
Molecular modeling studies were performed both on Linux and
Windows machines. The following software were used: a) MOE
2008.10 (http://www.chemcomp.com/) for sequence alignment
and homology modeling of the SceOSC enzyme wild type and of
the mutants; b) ANM (Anisotropic network model) for the analysis
of vibrational motions (http://ignmtest.ccbb.pitt.edu/cgi-bin/
anm/anm1.cgi); c) CAVER (http://loschmidt.chemi.muni.cz/
caver/index.php) for identifying and visualizing routes from the
interior of the protein to the bulk solvent and d) Pymol (http://
pymol.sourceforge.net/) for visualization and figures preparation.
Homology modeling
Sequence information of SceOSC was taken from the Uni-
ProtKB/Swiss-Prot database (http://www.uniprot.org/uniprot/
P38604). The X-Ray structure used as template for homology
modeling was downloaded from the Protein Data Bank (HsaOSC,
pdb code 1w6k).
Homology modeling was performed by using the homology
model tool of MOE. By default, MOE-homology produces 10
models, each is generated by making a series of Boltzmann-
weighted choices of side chain rotamers and loop conformations
from a set of protein fragments selected from the built-in library of
high-resolution protein structures. Starting from the SceOSC
sequence (see above) and the HsaOSC template structure (see
above), MOE generates ten energy-minimised models (M1-M10)
Figure 7. Results summing-up. A complete depiction of the structural requirements of the channel apparatus conferring to OSCs the ability
(absent in SHCs) of a pre-catalytical recognition of the substrate is the challenge of the next future. Other mutants shall be built and tested starting
from the most highly conserved residues of the SHC channel, replaced by different, yet highly conserved, residues in eukaryotic OSCs.
doi:10.1371/journal.pone.0022134.g007
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which were checked by both by MOE homology score and
WHAT IF (http://swift.cmbi.ru.nl/servers/html/index.html).
Both tools individuated one model M8 as the best, and this was
submitted to a final minimization using the AMBER force field
until the RMS (Root mean Square) gradient was below 0.1 kcal/
mol; this was finally used as the SceOSC model.
Computational introduction of mutations
Mutants were built by applying the MOE tool named Rotamer
Explorer on the final homology model described above. For any
mutant, all conformers proposed by Rotamer Explorer were
investigated but given the limited variations of extracted
information, results refer to the conformer with the lowest energy.
Briefly, an important component of any modeling method to build
mutants is the prediction of side-chain conformations. The
Rotamer Library in MOE is a collection of all-atom side-chain
conformations derived from high quality X-ray crystal structures.
These conformations differ markedly from the traditional rotamer
libraries in that bond length and angle variations are permitted.
The intent of the MOE rotamer library is to provide adequate
coverage of the conformational space available to a sidechain and
not just encode dihedral preferences. Given the use of Rotamer
Explorer method, no additional minimization run was performed
on the obtained mutants.
Analysis of vibrational motions
ANM (Anisotropic network model) was used to perform the
analysis of vibrational motions of SceOSC. Briefly, ANM [23] is a
fast computational tool that provides a simulation of spatial
fluctuations of proteins in good agreement with traditional CPU
time-consuming normal-mode analysis using force fields of
molecular dynamics (MD) packages.
The homology model of SceOSC was used as an input to
investigate the first 20 dominant modes (good representation of all
modes) with standard cutoff values (15 A˚).
Supporting Information
Figure S1 Mutations on position 525 fill in a different
way the channel to the binding site (shown surface). Left:
control mutant C457D; middle: C457D/A525I; right: C457D/
A525F.
(TIF)
Figure S2 The correlations in fluctuations between
residues for residues His193 (black circles), Asn211
(grey triangles), His291 (white squares), Glu526 (empty
triangle) and Cys457 (grey crosses) as a comparison.
(TIF)
Text S1 Detailed results of ANM study.
(DOC)
Table S1 SceOSC active site involved residues as
deduced after superposition with HsaOSC.
(DOC)
Table S2 MOE Protein contacts tool monitors the
network of interactions of residues 193, 211 and 291 in
investigated mutants.
(DOC)
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